Health / Medical Topics |
mRNA-derived Lung Cancer Vaccine CV9202
A non-small cell lung cancer (NSCLC) vaccine containing six modified mRNAs, which encode six different NSCLC associated antigens, with potential antitumor and immunomodulatory activities. Upon intradermal administration, mRNA-derived lung cancer vaccine CV9202 may stimulate the immune system to mount both humoral and cellular responses against NSCLC cells. The six tumor-associated antigens (TAAs) encoded by these mRNAs are frequently expressed by NSCLC cells and are minimally expressed or absent in normal, healthy cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
An RNA transport gene that encodes a protein specifically involved in the transport of mRNA.
mRNA Surveillance works within elaborate cellular mechanisms to ensure accurate gene expression by assessing suitable mRNA quality for translation and prevents the…
The synthesis or transcription of messenger RNA.
Transport of messenger RNA from its nuclear site of transcription to the cytoplasm, where the message is translated into protein by…
A type of RNA found in cells. mRNA molecules carry the genetic information needed to make proteins. They carry the information…
Magnetic resonance imaging (MRI) uses a large magnet and radio waves to look at organs and structures inside your body. Health care…